These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7907550)

  • 1. Linkage between phosphorylated cystatin alpha and filaggrin by epidermal transglutaminase as a model of cornified envelope and inhibition of cathepsin L activity by cornified envelope and the conjugated cystatin alpha.
    Takahashi M; Tezuka T; Kakegawa H; Katunuma N
    FEBS Lett; 1994 Mar; 340(3):173-6. PubMed ID: 7907550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Filaggrin linker segment peptide and cystatin alpha are parts of a complex of the cornified envelope of epidermis.
    Takahashi M; Tezuka T; Katunuma N
    Arch Biochem Biophys; 1996 May; 329(1):123-6. PubMed ID: 8619628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated cystatin alpha is a natural substrate of epidermal transglutaminase for formation of skin cornified envelope.
    Takahashi M; Tezuka T; Katunuma N
    FEBS Lett; 1992 Aug; 308(1):79-82. PubMed ID: 1353732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cysteine protease and growth of Staphylococcus aureus V8 and poliovirus by phosphorylated cystatin alpha conjugate of skin.
    Takahashi M; Tezuka T; Korant B; Katunuma N
    Biofactors; 1999; 10(4):339-45. PubMed ID: 10619701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat epidermal cathepsin L-like proteinase: purification and some hydrolytic properties toward filaggrin and synthetic substrates.
    Kawada A; Hara K; Hiruma M; Noguchi H; Ishibashi A
    J Biochem; 1995 Aug; 118(2):332-7. PubMed ID: 8543567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of growth and cysteine proteinase activity of Staphylococcus aureus V8 by phosphorylated cystatin alpha in skin cornified envelope.
    Takahashi M; Tezuka T; Katunuma N
    FEBS Lett; 1994 Dec; 355(3):275-8. PubMed ID: 7988688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties and nature of a cysteine proteinase inhibitor located in keratohyalin granules of rat epidermis.
    Takahashi M; Tezuka T; Towatari T; Katunuma N
    FEBS Lett; 1990 Jul; 267(2):261-4. PubMed ID: 2199217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiation.
    Egberts F; Heinrich M; Jensen JM; Winoto-Morbach S; Pfeiffer S; Wickel M; Schunck M; Steude J; Saftig P; Proksch E; Schütze S
    J Cell Sci; 2004 May; 117(Pt 11):2295-307. PubMed ID: 15126630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification.
    Cheng T; Hitomi K; van Vlijmen-Willems IM; de Jongh GJ; Yamamoto K; Nishi K; Watts C; Reinheckel T; Schalkwijk J; Zeeuwen PL
    J Biol Chem; 2006 Jun; 281(23):15893-9. PubMed ID: 16565075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal differentiation: the role of proteases and their inhibitors.
    Zeeuwen PL
    Eur J Cell Biol; 2004 Dec; 83(11-12):761-73. PubMed ID: 15679120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for different inhibitory specificities of human cystatins C and D.
    Hall A; Ekiel I; Mason RW; Kasprzykowski F; Grubb A; Abrahamson M
    Biochemistry; 1998 Mar; 37(12):4071-9. PubMed ID: 9521728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colocalization of cystatin M/E and its target proteases suggests a role in terminal differentiation of human hair follicle and nail.
    Cheng T; van Vlijmen-Willems IM; Hitomi K; Pasch MC; van Erp PE; Schalkwijk J; Zeeuwen PL
    J Invest Dermatol; 2009 May; 129(5):1232-42. PubMed ID: 19005484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic domains of cystatins linked to enkephalins are novel inhibitors of brain cathepsins L/B.
    Marks N; Berg MJ; Makofske RC; Danho W
    Peptides; 1990; 11(4):679-82. PubMed ID: 2235677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between ovine cathepsin L, cystatin C and alpha 2-macroglobulin. Potential role in the genital tract.
    Peloille S; Esnard A; Dacheux JL; Guillou F; Gauthier F; Esnard F
    Eur J Biochem; 1997 Feb; 244(1):140-6. PubMed ID: 9063457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin L is capable of truncating cystatin C of 11 N-terminal amino acids.
    Popovic T; Cimerman N; Dolenc I; Ritonja A; Brzin J
    FEBS Lett; 1999 Jul; 455(1-2):92-6. PubMed ID: 10428479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hairpin loop mutations of chicken cystatin have different effects on the inhibition of cathepsin B, cathepsin L and papain.
    Auerswald EA; Nägler DK; Assfalg-Machleidt I; Stubbs MT; Machleidt W; Fritz H
    FEBS Lett; 1995 Mar; 361(2-3):179-84. PubMed ID: 7698319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that filaggrin is a component of cornified cell envelopes in human plantar epidermis.
    Simon M; Haftek M; Sebbag M; Montézin M; Girbal-Neuhauser E; Schmitt D; Serre G
    Biochem J; 1996 Jul; 317 ( Pt 1)(Pt 1):173-7. PubMed ID: 8694761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cysteine proteinases and their inhibitor, cystatin beta, in cultured rat mesangial cells.
    Makita Y; Ishidoh K; Kominami E; Funabiki K; Koide H; Tomino Y
    J Diabetes Complications; 1998; 12(6):328-36. PubMed ID: 9877467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for filaggrin as a component of the cell envelope of the newborn rat.
    Richards S; Scott IR; Harding CR; Liddell JE; Powell GM; Curtis CG
    Biochem J; 1988 Jul; 253(1):153-60. PubMed ID: 3421939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of epidermal-type transglutaminase (transglutaminase 3) in human stratified epithelia and cultured keratinocytes using monoclonal antibodies.
    Hitomi K; Presland RB; Nakayama T; Fleckman P; Dale BA; Maki M
    J Dermatol Sci; 2003 Aug; 32(2):95-103. PubMed ID: 12850301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.